Cargando…
Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation
PURPOSE: The second-generation multi-electrode catheter, pulmonary vein ablation catheter (PVAC) GOLD, was designed to improve the delivery of phased radiofrequency energy and reduce procedure times using a ‘single-shot’ approach for pulmonary vein isolation (PVI), while retaining efficacy and safet...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925470/ https://www.ncbi.nlm.nih.gov/pubmed/32253598 http://dx.doi.org/10.1007/s10840-020-00728-8 |
_version_ | 1783659274616963072 |
---|---|
author | Klaver, M. N. Wintgens, L. I. S. Wijffels, M. C. E. F. Balt, J. C. van Dijk, V. F. Alipour, A. Chaldoupi, S. M. Derksen, R. Boersma, L. V. A. |
author_facet | Klaver, M. N. Wintgens, L. I. S. Wijffels, M. C. E. F. Balt, J. C. van Dijk, V. F. Alipour, A. Chaldoupi, S. M. Derksen, R. Boersma, L. V. A. |
author_sort | Klaver, M. N. |
collection | PubMed |
description | PURPOSE: The second-generation multi-electrode catheter, pulmonary vein ablation catheter (PVAC) GOLD, was designed to improve the delivery of phased radiofrequency energy and reduce procedure times using a ‘single-shot’ approach for pulmonary vein isolation (PVI), while retaining efficacy and safety. This large registry presents acute success rates and safety outcomes in a daily practice setting. METHODS: A total of 1017 patients undergoing first-time ablation for atrial fibrillation (AF) using PVAC GOLD were included, 644 patients with paroxysmal AF and 373 patients with non-paroxysmal AF, divided into 175 patients receiving PVI only and 198 patients receiving PVI with additional substrate modification. RESULTS: High and comparable percentages of successful PVI could be achieved in all groups (98%, 95% and 99%; p = 0.108). The median total procedure time for all groups was 90 min [70–100]. As expected, the total procedure, ablation and fluoroscopy time were significantly longer in the PVI + substrate modification group compared with the PVI-only cases (all p < 0.001), but not between the PVI-only groups (p = 0.306, p = 0.088, p = 0.233, respectively). A total of 44 complications were observed in 43 patients (4.2%). Major complications were seen in 19 patients (1.87%) and non-major procedure–related complications were seen in 25 patients (2.46%). Complications leaving permanent sequelae were rare and occurred in only four patients (0.39%). Complications did not differ between groups (p = 0.199, p = 0.438, p = 0.240 and p = 0.465 respectively). CONCLUSION: PVAC GOLD performs successful PVI, while reducing procedure times and retaining safety for paroxysmal, persistent and long-standing persistent AF. Safety was unaffected by additional substrate modification. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10840-020-00728-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7925470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-79254702021-03-19 Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation Klaver, M. N. Wintgens, L. I. S. Wijffels, M. C. E. F. Balt, J. C. van Dijk, V. F. Alipour, A. Chaldoupi, S. M. Derksen, R. Boersma, L. V. A. J Interv Card Electrophysiol Multimedia Report PURPOSE: The second-generation multi-electrode catheter, pulmonary vein ablation catheter (PVAC) GOLD, was designed to improve the delivery of phased radiofrequency energy and reduce procedure times using a ‘single-shot’ approach for pulmonary vein isolation (PVI), while retaining efficacy and safety. This large registry presents acute success rates and safety outcomes in a daily practice setting. METHODS: A total of 1017 patients undergoing first-time ablation for atrial fibrillation (AF) using PVAC GOLD were included, 644 patients with paroxysmal AF and 373 patients with non-paroxysmal AF, divided into 175 patients receiving PVI only and 198 patients receiving PVI with additional substrate modification. RESULTS: High and comparable percentages of successful PVI could be achieved in all groups (98%, 95% and 99%; p = 0.108). The median total procedure time for all groups was 90 min [70–100]. As expected, the total procedure, ablation and fluoroscopy time were significantly longer in the PVI + substrate modification group compared with the PVI-only cases (all p < 0.001), but not between the PVI-only groups (p = 0.306, p = 0.088, p = 0.233, respectively). A total of 44 complications were observed in 43 patients (4.2%). Major complications were seen in 19 patients (1.87%) and non-major procedure–related complications were seen in 25 patients (2.46%). Complications leaving permanent sequelae were rare and occurred in only four patients (0.39%). Complications did not differ between groups (p = 0.199, p = 0.438, p = 0.240 and p = 0.465 respectively). CONCLUSION: PVAC GOLD performs successful PVI, while reducing procedure times and retaining safety for paroxysmal, persistent and long-standing persistent AF. Safety was unaffected by additional substrate modification. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10840-020-00728-8) contains supplementary material, which is available to authorized users. Springer US 2020-04-06 2021 /pmc/articles/PMC7925470/ /pubmed/32253598 http://dx.doi.org/10.1007/s10840-020-00728-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Multimedia Report Klaver, M. N. Wintgens, L. I. S. Wijffels, M. C. E. F. Balt, J. C. van Dijk, V. F. Alipour, A. Chaldoupi, S. M. Derksen, R. Boersma, L. V. A. Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation |
title | Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation |
title_full | Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation |
title_fullStr | Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation |
title_full_unstemmed | Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation |
title_short | Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation |
title_sort | acute success and safety of the second-generation pvac gold phased rf ablation catheter for atrial fibrillation |
topic | Multimedia Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925470/ https://www.ncbi.nlm.nih.gov/pubmed/32253598 http://dx.doi.org/10.1007/s10840-020-00728-8 |
work_keys_str_mv | AT klavermn acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation AT wintgenslis acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation AT wijffelsmcef acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation AT baltjc acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation AT vandijkvf acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation AT alipoura acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation AT chaldoupism acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation AT derksenr acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation AT boersmalva acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation |